"Glucose Tolerance Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
| Descriptor ID |
D005951
|
| MeSH Number(s) |
E01.370.225.124.100.355 E01.370.374.355 E05.200.124.100.355
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucose Tolerance Test".
Below are MeSH descriptors whose meaning is more specific than "Glucose Tolerance Test".
This graph shows the total number of publications written about "Glucose Tolerance Test" by people in this website by year, and whether "Glucose Tolerance Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 6 | 8 |
| 2003 | 1 | 5 | 6 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 2 | 6 | 8 |
| 2009 | 0 | 9 | 9 |
| 2010 | 0 | 4 | 4 |
| 2011 | 1 | 4 | 5 |
| 2012 | 0 | 8 | 8 |
| 2013 | 3 | 3 | 6 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 3 | 3 |
| 2016 | 1 | 6 | 7 |
| 2017 | 0 | 6 | 6 |
| 2018 | 2 | 7 | 9 |
| 2019 | 0 | 5 | 5 |
| 2020 | 2 | 6 | 8 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 3 | 3 |
| 2024 | 2 | 6 | 8 |
| 2025 | 0 | 9 | 9 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Tolerance Test" by people in Profiles.
-
Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross-sectional analysis of the microbiome and insulin longitudinal evaluation study (MILES). Diabetes Obes Metab. 2025 10; 27(10):5444-5454.
-
Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin. Nat Commun. 2021 09 06; 12(1):5296.
-
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients. J Cyst Fibros. 2021 03; 20(2):333-338.
-
Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes Obes Metab. 2020 11; 22(11):1976-1984.
-
Evaluating a pragmatic estimate of insulin sensitivity in Latino youth with obesity. Clin Obes. 2020 Apr; 10(2):e12353.
-
Sleeve gastrectomy rapidly enhances islet function independently of body weight. JCI Insight. 2019 03 21; 4(6).
-
Associations Among Sleep, Body Mass Index, Waist Circumference, and Risk of Type 2 Diabetes Among U.S. Childbearing-Age Women: National Health and Nutrition Examination Survey. J Womens Health (Larchmt). 2018 11; 27(11):1400-1407.
-
Folate treatment partially reverses gestational low-protein diet-induced glucose intolerance and the magnitude of reversal is age and sex dependent. Nutrition. 2018 05; 49:81-89.
-
Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity. Mol Metab. 2017 11; 6(11):1350-1359.
-
Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance. J Pediatr. 2016 Nov; 178:171-177.